“Medication” on The Daily Caller

NEW YORK (AP) — Shares of Amgen Inc. fell Thursday on concerns that the Food and Drug Administration’s plans to re-examine the safety of anemia drugs, which could put more pressure on sales of leading anemia treatments Aranesp and Epogen. (more)

BRUSSELS (AP) — European Union regulators said Thursday that they suspect Danish drug maker Lundbeck may have delayed the launch of a cheaper, generic version of its antidepressant drug in Europe. (more)

WASHINGTON (AP) — Drug approvals from the Food and Drug Administration were flat last year compared with 2008 and warnings fell, even as the agency’s new leadership struck a tougher stance on safety. (more)